FRESH THINKING, BETTER OUTCOMES

Your products touch lives. At Pharmatech Associates, we help life science companies bring these products to market worldwide. Navigating the complex and interconnected regulatory processes require technical expertise in compliance, product and process development, validation, and regulatory affairs. We call this the Pharmatech Ecosystem.

And that means better outcomes for our clients’ patients.

Our process

VALUE IN OUR PROCESS

Our Subject Matter Experts have fully integrated development knowledge, hands on experience, and the ability to respond rapidly with pragmatic solutions, by applying proven and effective systems and practices. Our diligence in managing budget and timeline processes provides measurable value. As a result, our clients consistently rank us in the top-tier of life sciences industry consultants providing similar services. For Pharmatech, this has translated into a customer retention rate among the best in the industry, with some clients choosing to partner with Pharmatech since its inception in 1995.

LEARN MORE ABOUT WHAT WE DO  

Our process

VALUE IN OUR PROCESS

Our Subject Matter Experts have fully integrated development knowledge, hands on experience, and the ability to respond rapidly with pragmatic solutions, by applying proven and effective systems and practices. Our diligence in managing budget and timeline processes provides measurable value. As a result, our clients consistently rank us in the top-tier of life sciences industry consultants providing similar services. For Pharmatech, this has translated into a customer retention rate among the best in the industry, with some clients choosing to partner with Pharmatech since its inception in 1995.

Our process

PRODUCT & PROCESS DEVELOPMENT

Bringing a medical product to market is a complex undertaking. The product development processes require a proven, systematic approach that balances product quality, regulatory risk and stakeholder demands to minimize time to market.

Our process

VALIDATION

Validation requires the rigorous application of systematic GMP structure to ensure that quality is maintained at every stage from development through production. It involves the commissioning and qualification of facilities, systems, equipment, products and processes using proven methods.

Our process

COMPLIANCE

A regulatory compliance business relationship begins with a strong fiduciary bond. Partnering with a regulatory compliance expert gives you the insight and experience needed to ensure program success with regulatory authorities worldwide.

Our process

REGULATORY

Expert knowledge and experience matter during the regulatory approval process. Gaining approval requires a diligent scientific and statistical foundation upon which carefully structured and articulately drafted documents are used to make the case for your product’s rapid and successful approval.

WHAT'S NEW?

Visit Pharmatech Associates at the Outsourced Pharma Event on Aug 22-24 in La Jolla, CA at the Hyatt Regency, Booth #36. More News  

FRESH THINKING, BETTER OUTCOMES

The Pharmatech Difference

Bikash Chatterjee, President and Chief Scientific Officer, introduces you to the breadth and depth of knowledge and expertise possessed by our staff of Associates and SMEs at Pharmatech, and explains our unique approach to advising and providing technical services to our clients, that has been the basis for our decades of success in the Regulated Life Science industry.

LEARN MORE ABOUT PHARMATECH  

Contact Us

Pharmatech Associates, Inc.
22320 Foothill Blvd. Suite 330
Hayward CA 94541

Phone: 510.732.0177
Fax: 510.732.1992 
TF: 877.787.0177

  Let’s Connect!

Quality Circle: Profitability, Integrity and the Cost of Poor Quality

As major blockbuster drugs come off patent, the scramble among generics to capture these new markets is just beginning. We can expect the U.S. market to experience continued change and consolidation with cost cutting remaining at the top of the priority list for big pharma. We can also expect emerging market drug powerhouses to try and gain market share as these blockbusters come off patent.

12/ 16/ 2014

READ FULL BLOG POST